Direkt zum Inhalt

Cochrane method or tool interest form

Proposals to change methods and tools are assessed by the Methods Executive following the process outlined on the Cochrane Methods website

Person completing this form
List all Cochrane groups and entities with which you are affiliated using separate rows.
List lead researchers or developers, if known, using separate rows.
Briefly detail why you think Cochrane should consider the method or tool and how you envision it being used in Cochrane reviews. Please state whether your proposal is to replace an existing method or if it is to be used in parallel with current methods. If the latter, please state which existing methods this new approach should complement or be used alongside. Please state if you are seeking Cochrane’s approval, endorsement, mandate or other (<200 words).
Briefly detail which Methods Groups you have been in contact with and describe the level of collaboration and any support for the development of your proposal, if any. A list of the Methods Groups can be found here (<200 words).
Briefly describe the aims and objectives of the method or development (<200 words).
Briefly describe the key features of the method or development or methodological problem. Please state whether the method should be applied in standard Cochrane reviews, specific types of reviews or whether more experimental (<300 words).
Briefly detail the strengths and limitations of the method or tool, including scenarios when it is best suited and when it may be inappropriate to use. This is particularly important for methods and tools using artificial intelligence.
Briefly highlight any potential implementation considerations you envision, including, but not limited to; developments to Cochrane systems or tools, e.g. RevMan functionality or integration; specific requirement for publications and how it is visualised; whether it generates large datasets, how these should be managed and whether they should be published; any costs associated with its use; any ethical or other legal considerations, e.g., copyright, privacy, etc. for authors or Cochrane; and requirements for training authors, editors and/or peer reviewers, etc.   
Briefly describe support from published guidance or evaluation of the method or tool with information on its development and acceptability (<200 words). If applicable, please list primary references. You can upload unpublished documents, such as proof of performance, details of testing or piloting, information on the acceptability of the method or tool, or other guidance using the link below. 
Files must be less than 2 MB. Allowed file types: html pdf doc docx ppt pptx xls xlsx.
Nur eine Datei möglich.
2 MB Limit.
Erlaubte Dateitypen: html, pdf, doc, docx, ppt, pptx, xls, xlsx.

So verwenden wir Cookies

Wir verwenden notwendige Cookies, damit unsere Webseite funktioniert. Wir möchten auch optionale Cookies für Google Analytics setzen, um unsere Webseite zu verbessern. Solche optionalen Cookies setzen wir nur, wenn Sie dies zulassen. Wenn Sie dieses Programm aufrufen, wird ein Cookie auf Ihrem Gerät platziert, um Ihre Präferenzen zu speichern. Sie können Ihre Cookie-Einstellungen jederzeit ändern, indem Sie auf den Link "Cookie-Einstellungen" am Ende jeder Seite klicken.
Auf unserer Seite zu Cookies finden Sie weitere Informationen, wie diese Cookies funktionieren die Seite mit den Cookies.

Alle akzeptieren
Anpassen